
Ami Organics (AMIORG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
3.1B
Gross Profit
1.5B
47.33%
Operating Income
776.6M
25.17%
Net Income
627.2M
20.33%
Balance Sheet Metrics
Total Assets
15.5B
Total Liabilities
2.3B
Shareholders Equity
13.2B
Debt to Equity
0.17
Cash Flow Metrics
Revenue & Profitability Trend
Ami Organics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 10.1B | 7.1B | 6.1B | 5.2B | 3.4B |
Cost of Goods Sold | 5.5B | 4.5B | 3.7B | 2.7B | 2.2B |
Gross Profit | 4.5B | 2.6B | 2.4B | 2.5B | 1.2B |
Gross Margin % | 45.2% | 36.2% | 39.0% | 47.5% | 35.0% |
Operating Expenses | |||||
Research & Development | - | 0 | 2.7M | 1.2M | 6.7M |
Selling, General & Administrative | - | 218.6M | 246.1M | 246.3M | 91.3M |
Other Operating Expenses | 1.4B | 483.4M | 450.1M | 1.0B | 101.5M |
Total Operating Expenses | 1.4B | 701.9M | 698.9M | 1.3B | 199.5M |
Operating Income | 2.1B | 1.1B | 1.1B | 951.0M | 764.3M |
Operating Margin % | 20.4% | 15.8% | 18.1% | 18.3% | 22.7% |
Non-Operating Items | |||||
Interest Income | - | 21.3M | 21.8M | 25.8M | 2.0M |
Interest Expense | 62.2M | 59.4M | 24.1M | 64.1M | 52.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 2.2B | 819.0M | 1.1B | 914.5M | 717.3M |
Income Tax | 557.5M | 331.9M | 288.8M | 195.0M | 177.3M |
Effective Tax Rate % | 25.8% | 40.5% | 25.7% | 21.3% | 24.7% |
Net Income | 1.6B | 487.1M | 832.9M | 719.5M | 540.0M |
Net Margin % | 15.9% | 6.8% | 13.6% | 13.8% | 16.1% |
Key Metrics | |||||
EBITDA | 2.5B | 1.4B | 1.3B | 1.1B | 815.8M |
EPS (Basic) | ₹9.91 | ₹11.67 | ₹22.86 | ₹21.03 | ₹17.14 |
EPS (Diluted) | ₹9.91 | ₹11.66 | ₹22.86 | ₹21.03 | ₹17.14 |
Basic Shares Outstanding | 81868922 | 36666082 | 36437062 | 34211175 | 36437062 |
Diluted Shares Outstanding | 81868922 | 36666082 | 36437062 | 34211175 | 36437062 |
Income Statement Trend
Ami Organics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.9B | 297.0M | 305.3M | 103.0M | 26.8M |
Short-term Investments | 637.0M | 236.1M | 281.4M | 512.5M | - |
Accounts Receivable | 2.9B | 2.1B | 2.3B | 1.6B | 1.2B |
Inventory | 1.8B | 1.6B | 1.2B | 1.1B | 603.6M |
Other Current Assets | 701.1M | 753.5M | 1.0K | 481.3M | 3.7M |
Total Current Assets | 7.9B | 5.0B | 4.6B | 4.3B | 2.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 5.1B | 387.2M | 383.9M | 1.8B | 184.3M |
Goodwill | 1.2B | 1.2B | 617.8M | 453.2M | 436.3M |
Intangible Assets | 82.8M | 103.0M | 211.4M | 81.3M | 257.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 516.7M | -2.0K | - | 66.6M | 62.0M |
Total Non-Current Assets | 7.6B | 6.0B | 3.1B | 2.3B | 2.0B |
Total Assets | 15.5B | 11.0B | 7.7B | 6.6B | 4.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.6B | 1.3B | 1.4B | 1.2B | 847.8M |
Short-term Debt | 81.8M | 1.0B | 29.7M | 2.6M | 639.9M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 134.8M | 343.6M | 64.3M | 46.3M | 20.0K |
Total Current Liabilities | 2.0B | 2.9B | 1.6B | 1.3B | 1.7B |
Non-Current Liabilities | |||||
Long-term Debt | 47.5M | 1.1B | 6.3M | 5.9M | 726.4M |
Deferred Tax Liabilities | 196.3M | 130.2M | 88.3M | 62.6M | 32.8M |
Other Non-Current Liabilities | - | - | - | - | -2.0K |
Total Non-Current Liabilities | 269.3M | 1.3B | 101.3M | 72.9M | 802.9M |
Total Liabilities | 2.3B | 4.1B | 1.7B | 1.4B | 2.5B |
Equity | |||||
Common Stock | 409.3M | 368.8M | 364.4M | 364.4M | 315.0M |
Retained Earnings | - | 3.1B | 2.8B | 2.0B | 1.3B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 13.2B | 6.8B | 5.9B | 5.2B | 1.7B |
Key Metrics | |||||
Total Debt | 129.4M | 2.2B | 36.0M | 8.4M | 1.4B |
Working Capital | 5.9B | 2.1B | 2.9B | 3.0B | 501.9M |
Balance Sheet Composition
Ami Organics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.2B | 819.0M | 1.1B | 914.5M | 717.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 9.3M | 23.1M | 0 | - | - |
Working Capital Changes | -1.0B | -76.3M | -655.3M | -1.3B | -735.2M |
Operating Cash Flow | 1.1B | 803.2M | 468.8M | -345.0M | 31.2M |
Investing Activities | |||||
Capital Expenditures | -1.9B | -2.8B | -964.0M | -337.6M | -1.0B |
Acquisitions | - | - | - | - | - |
Investment Purchases | -401.0M | -660.3M | - | -2.8M | - |
Investment Sales | - | 130.3M | 611.8M | - | 34.6M |
Investing Cash Flow | -2.3B | -3.7B | 258.9M | -1.2B | -1.0B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -122.8M | -109.3M | -109.4M | - | - |
Debt Issuance | - | 1.3B | 0 | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 3.9B | 2.5B | -81.8M | 3.0B | 0 |
Free Cash Flow | -763.0M | -1.6B | -308.7M | -456.9M | -791.5M |
Net Change in Cash | 2.7B | -420.0M | 645.9M | 1.4B | -980.0M |
Cash Flow Trend
Ami Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
119.06
Forward P/E
24.36
Price to Book
7.20
Price to Sales
9.56
PEG Ratio
24.36
Profitability Ratios
Profit Margin
15.76%
Operating Margin
25.17%
Return on Equity
16.02%
Return on Assets
9.71%
Financial Health
Current Ratio
3.91
Debt to Equity
0.98
Beta
-0.06
Per Share Data
EPS (TTM)
₹9.88
Book Value per Share
₹163.49
Revenue per Share
₹125.67
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
amiorg | 96.3B | 119.06 | 7.20 | 16.02% | 15.76% | 0.98 |
Asian Paints | 2.4T | 65.80 | 12.24 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
BASF India | 199.1B | 50.25 | 5.48 | 13.18% | 2.61% | 5.23 |
Atul | 195.2B | 39.07 | 3.49 | 8.55% | 8.71% | 3.56 |
Kansai Nerolac | 188.0B | 16.61 | 2.93 | 17.85% | 14.43% | 4.63 |
Financial data is updated regularly. All figures are in the company's reporting currency.